Literature DB >> 8700511

Isolation and characterization of genes associated with chromosome-6 mediated tumor suppression in human malignant melanoma.

M E Ray1, Y A Su, P S Meltzer, J M Trent.   

Abstract

Melanocytic transformation is thought to occur by the sequential accumulation of genetic alterations. Evidence implicating human chromosomes as a site for a gene(s) involved in melanoma suppression comes from studies of LOH [loss of heterozygosity], cytogenetics and biologic reversion of tumorigenicity following the introduction of a normal chromosome 6 by microcell-mediated chromosome transfer (Trent et al., 1990). Using a tumorigenic melanoma cell line (UACC 903) and a chromosome-6 suppressed melanoma subline [UACC 903 (+6)], we have isolated a series of genes uniquely expressed in the suppressed subline. A modified PCR-based cDNA subtraction technique was used to generate subtracted cDNA sublibraries for both the parental and (+6) suppressed cells. A total of 32 randomly selected clones from the suppressed sublibrary were isolated and examined, with 24 detecting a transcript by Northern analysis. Of these 24 clones, 21 (88%) demonstrated elevated expressed by Northern analysis in the suppressed subline relative to the tumorigenic parental cell line. In 6/21 differentially expressed clones (29%), expression was exclusive to the suppressed subline. Partial sequence analysis and database searching of these clones indicated that 5/6 were novel with one representing a previously characterized gene. Chromosomal localization of the five novel clones was performed following PCR amplification of a human/rodent somatic cell hybrid mapping panel or fluorescent in situ hybridization. One cDNA (termed AIM1) was localized to a band-region of chromosome 6 frequently deleted in melanomas (6q21). This novel approach should facilitate the identification of genes whose expression is causally related to the suppressed phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700511

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Transcription and growth regulatory functions of the HIN-200 family of proteins.

Authors:  R W Johnstone; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.

Authors:  A Barghorn; E J Speel; B Farspour; P Saremaslani; S Schmid; A Perren; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma.

Authors:  M E Ray; G Wistow; Y A Su; P S Meltzer; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.

Authors:  Marion Travert; Yenlin Huang; Laurence de Leval; Nadine Martin-Garcia; Marie-Helene Delfau-Larue; Françoise Berger; Jacques Bosq; Josette Brière; Jean Soulier; Elizabeth Macintyre; Teresa Marafioti; Aurélien de Reyniès; Philippe Gaulard
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

Review 5.  Functions of crystallins in and out of lens: roles in elongated and post-mitotic cells.

Authors:  Christine Slingsby; Graeme J Wistow
Journal:  Prog Biophys Mol Biol       Date:  2014-02-28       Impact factor: 3.667

6.  Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.

Authors:  Alla Musiyenko; Vira Bitko; Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2008-01-12       Impact factor: 4.599

7.  High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

Authors:  Paula Vainio; John-Patrick Mpindi; Pekka Kohonen; Vidal Fey; Tuomas Mirtti; Kalle A Alanen; Merja Perälä; Olli Kallioniemi; Kristiina Iljin
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

8.  Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals.

Authors:  Shunichi Terasaka; Yukie Aita; Akio Inoue; Shinichi Hayashi; Michiko Nishigaki; Kazuhiko Aoyagi; Hiroki Sasaki; Yuko Wada-Kiyama; Yasuo Sakuma; Shuichi Akaba; Junko Tanaka; Hideko Sone; Junzo Yonemoto; Masao Tanji; Ryoiti Kiyama
Journal:  Environ Health Perspect       Date:  2004-05       Impact factor: 9.031

9.  BRN2 is a non-canonical melanoma tumor-suppressor.

Authors:  Michael Hamm; Pierre Sohier; Valérie Petit; Jérémy H Raymond; Véronique Delmas; Madeleine Le Coz; Franck Gesbert; Colin Kenny; Zackie Aktary; Marie Pouteaux; Florian Rambow; Alain Sarasin; Nisamanee Charoenchon; Alfonso Bellacosa; Luis Sanchez-Del-Campo; Laura Mosteo; Martin Lauss; Dies Meijer; Eirikur Steingrimsson; Göran B Jönsson; Robert A Cornell; Irwin Davidson; Colin R Goding; Lionel Larue
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

Review 10.  The human crystallin gene families.

Authors:  Graeme Wistow
Journal:  Hum Genomics       Date:  2012-12-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.